| Literature DB >> 31146454 |
Lan Guo1,2, Tian Wang3,4, Wanxin Wang5,6, Guoliang Huang7, Yan Xu8, Ciyong Lu9,10.
Abstract
Adolescent health-risk behaviors can have long lasting negative effects throughout an individual's life, and cause a major economic and social burden to society. This study aimed to estimate the prevalence of the health-risk behaviors among Chinese adolescents and to test the trends in health-risk behaviors without and with adjusting for sociodemographic characteristics. Data were drawn from the School-based Chinese Adolescents Health Survey, which is an ongoing school-based study about the health-risk behaviors among Chinese adolescents (7th to 12th grade). During the first wave through the third wave, the prevalence of lifetime, past 12-month, and past 30-day use of opioid decreased by 4.19%, 0.63%, and 0.56%, respectively. Moreover, the prevalence of lifetime, past 12-month, and past 30-day sedative use decreased by 3.03%, 0.65%, and 0.35%, respectively. During the three waves, most trends in the prevalence of health-risk behaviors were downward, with a few exceptions: The prevalence of lifetime smoking, drinking, methamphetamine use, and sleep disturbance increased by 7.15%, 13.08%, 0.48%, and 9.06%, respectively. The prevalence of lifetime 3,4-methylene dioxy methamphetamine use (from 0.49% to 0.48%), lifetime mephedrone use (from 0.30% to 0.24%), or suicide attempts (from 2.41% to 2.46%) remained stable.Entities:
Keywords: adolescent; health-risk behavior; trend; wave
Mesh:
Substances:
Year: 2019 PMID: 31146454 PMCID: PMC6603688 DOI: 10.3390/ijerph16111902
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Prevalence estimates of health-risk behaviors among Chinese adolescents.
| Variable | Prevalence (95% CI) | Unadjusted | Adjusted | ||
|---|---|---|---|---|---|
| 2012–2013 | 2014–2015 | 2016–2017 | |||
|
| |||||
| Lifetime | 6.18 (5.87–6.49) | 4.43 (4.14–4.72) | 1.99 (1.81–2.17) | <0.001 | <0.001 |
| Past 12-month | 1.74 (1.58–1.90) | 2.09 (1.89–2.29) | 1.11 (0.97–1.25) | <0.001 | <0.001 |
| Past 30-day | 1.08 (0.96–1.20) | 0.92 (0.78–1.06) | 0.52 (0.42–0.62) | <0.001 | <0.001 |
|
| |||||
| Lifetime | 4.05 (3.80–4.30) | 4.55 (4.26–4.84) | 1.02 (0.88–1.16) | <0.001 | <0.001 |
| Past 12-month | 1.37 (1.21–1.53) | 2.25 (2.03–2.47) | 0.72 (0.60–0.84) | <0.001 | <0.001 |
| Past 30-day | 0.77 (0.65–0.89) | 1.04 (0.90–1.18) | 0.42 (0.34–0.50) | <0.001 | <0.001 |
|
| 0.49 (0.41–0.57) | 0.42 (0.32–0.52) | 0.48 (0.38–0.58) | 0.11 | |
|
| 0 | 0.44 (0.34–0.54) | 0.48 (0.38–0.58) | <0.001 | <0.001 |
|
| 0.65 (0.55–0.75) | 0.55 (0.45–0.65) | 0.54 (0.44–0.64) | <0.001 | 0.858 |
|
| 0.30 (0.22–0.38) | 0.20 (0.14–0.26) | 0.24 (0.18–0.30) | <0.001 | <0.001 |
|
| 5.24 (4.95–5.53) | 5.25 (4.84–5.46) | 12.39 (11.94–12.84) | <0.001 | <0.001 |
|
| 20.10 (19.57–20.63) | 28.36 (27.56–29.16) | 29.15 (28.29–30.01) | <0.001 | <0.001 |
|
| 2.41 (2.21–2.61) | 2.57 (2.35–2.79) | 2.46 (2.26–2.66) | 0.04 | <0.001 |
|
| 43.67 (43.00–44.34) | 32.31 (31.62–33.00) | 52.73 (52.04–53.42) | <0.001 | <0.001 |
MDMA = 3,4-methylene dioxy methamphetamine; 95% CI = 95% confidence interval. * Adjusting for age, gender, living arrangement, household socioeconomic status, classmate relations, and teacher–classmate relations.
Figure 1Trends in health-risk behaviors among Chinese adolescents in Guangdong Province.
Trends in health-risk behaviors among Chinese adolescents: univariable and multivariable logistic regression showing time associated with health-risk behaviors.
| Variable | OR (95% CI) a | AOR (95% CI) a,* | ||
|---|---|---|---|---|
| Wave 2 (2014–2015) | Wave 3 (2016–2017) | Wave 2 (2014–2015) | Wave 3 (2016–2017) | |
| Lifetime Opioid use | 0.71 (0.69–0.72) | 0.31 (0.30–0.31) | 0.68 (0.67–0.69) | 0.30 (0.29–0.30) |
| Past 12-month Opioid use | 1.20 (1.18–1.23) | 0.63 (0.62–0.65) | 1.14 (1.09–1.14) | 0.58 (0.57–0.60) |
| Past 30-day Opioid use | 0.85 (0.82–0.87) | 0.48 (0.46–0.49) | 0.78 (0.76–0.80) | 0.43 (0.42–0.44) |
| Lifetime Sedative use | 1.13 (1.12–1.16) | 0.25 (0.24–0.25) | 1.18 (1.16–1.19) | 0.26 (0.26–0.27) |
| Past 12-month Sedative use | 1.66 (1.63–1.70) | 0.53 (0.51–0.54) | 1.69 (1.66–1.73) | 0.55 (0.53–0.57) |
| Past 30-day Sedative use | 1.36 (1.32–1.40) | 0.55 (0.53–0.57) | 1.40 (1.36–1.45) | 0.58 (0.55–0.60) |
| Lifetime MDMA use | 0.84 (0.81–0.88) | 1.04 (1.01–1.07) | 0.94 (0.90–0.98) | 1.11 (1.07–1.16) |
| Lifetime Methamphetamine use | NA | NA | NA | NA |
| Lifetime ketamine use | 0.85 (0.82–0.88) | 0.83 (0.80–0.86) | 0.99 (0.95–1.02) | 1.00 (0.97–1.04) |
| Lifetime Mephedrone use | 0.67 (0.63–0.71) | 0.78 (0.74–0.82) | 0.74 (0.70–0.78) | 0.90 (0.85–0.95) |
| Lifetime smoking | 1.02 (1.01–1.04) | 2.56 (2.53–2.59) | 1.20 (1.18–1.21) | 3.20 (3.17–3.24) |
| Lifetime drinking | 1.62 (1.55–1.70) | 1.76 (1.67–1.85) | 1.59 (1.51–1.68) | 1.71 (1.62–1.80) |
| Suicide attempts | 1.02 (1.01–1.06) | 1.07 (1.00–1.09) | 1.13 (1.11–1.15) | 1.15 (1.12–1.17) |
| Sleep disturbance | 0.62 (0.61–0.62) | 1.44 (1.43–1.45) | 0.74 (0.73–0.74) | 1.94 (1.93–1.95) |
a The category “wave 1 (2012–2013)” was treated as reference in the univariable and multivariable logistic regression analyses. OR = odds ratio; AOR = adjusted odds ratio; 95% CI = 95% confidence interval; MDMA = 3,4-methylene dioxy methamphetamine; NA = not applicable. * Adjusting for age, gender, living arrangement, household socioeconomic status, classmate relations, and teacher-classmate relations.